Investigation of structural and electronic biases in mutagenic compounds
暂无分享,去创建一个
[1] H O Villar,et al. Toward the design of chemical libraries for mass screening biased against mutagenic compounds. , 2001, Journal of medicinal chemistry.
[2] Hugo O. Villar,et al. Quantum mechanical parametrization of a conformationally dependent hydrophobic index , 1992 .
[3] Lahana,et al. How many leads from HTS? , 1999, Drug discovery today.
[4] Tudor I. Oprea,et al. Property distribution of drug-related chemical databases* , 2000, J. Comput. Aided Mol. Des..
[5] E Benfenati,et al. Computational predictive programs (expert systems) in toxicology. , 1997, Toxicology.
[6] J. Stewart. Optimization of parameters for semiempirical methods I. Method , 1989 .
[7] Ajay,et al. Can we learn to distinguish between "drug-like" and "nondrug-like" molecules? , 1998, Journal of medicinal chemistry.
[8] G H Loew,et al. Computer-assisted mechanistic structure-activity studies: application to diverse classes of chemical carcinogens. , 1985, Environmental health perspectives.
[9] T Ohta,et al. Recommendations for the performance of bacterial mutation assays. , 1994, Mutation research.
[10] Roger E. Critchlow,et al. Beyond mere diversity: tailoring combinatorial libraries for drug discovery. , 1999, Journal of combinatorial chemistry.
[11] D. Sanderson,et al. Computer Prediction of Possible Toxic Action from Chemical Structure; The DEREK System , 1991, Human & experimental toxicology.
[12] R. Mannhold,et al. 6-Substituted benzopyrans as potassium channel activators: synthesis, vasodilator properties, and multivariate analysis. , 1999, Journal of medicinal chemistry.
[13] Evans,et al. Approaches to higher-throughput pharmacokinetics (HTPK) in drug discovery. , 2000, Drug discovery today.
[14] G. Klopman. Artificial intelligence approach to structure-activity studies. Computer automated structure evaluation of biological activity of organic molecules , 1985 .
[15] H. Kubinyi,et al. A scoring scheme for discriminating between drugs and nondrugs. , 1998, Journal of medicinal chemistry.
[16] J. Ferrell,et al. Quantum chemical studies of polycyclic aromatic hydrocarbons and their metabolites: correlations to carcinogenicity. , 1979, Chemico-biological interactions.
[17] T. Nohmi,et al. Recent advances in the construction of bacterial genotoxicity assays. , 1997, Mutation research.
[18] G. Loew,et al. Metabolism and relative carcinogenic potency of chloroethylenes: a quantum chemical structure-activity study. , 1983, Chemico-biological interactions.
[19] Hugo O. Villar,et al. Exhaustive enumeration of molecular substructures , 1997 .
[20] G. Bemis,et al. The properties of known drugs. 1. Molecular frameworks. , 1996, Journal of medicinal chemistry.
[21] A. Beresford,et al. ADME/PK as part of a rational approach to drug discovery. , 2000, Drug discovery today.
[22] K. Enslein,et al. Use of SAR in computer-assited prediction of carcinogenicity and mutagenicity of chemicals by the TOPKAT program , 1994 .